Corbion 将来の成長

ENXTAM:CRBN - アナリストの将来予測と過去の財務データ ( )EUR Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	1,396	103	55	169	5
12/31/2025	1,334	86	68	177	5
12/31/2024	1,298	90	62	135	5
6/30/2024	1,439	80	66	171	N/A
3/31/2024	1,442	77	41	168	N/A
12/31/2023	1,444	73	16	165	N/A
9/30/2023	1,380	57	-61	121	N/A
6/30/2023	1,412	54	-139	77	N/A
3/31/2023	1,435	72	-168	58	N/A
12/31/2022	1,458	90	-197	39	N/A
9/30/2022	1,350	76	-190	32	N/A
6/30/2022	1,243	63	-184	25	N/A
3/31/2022	1,157	70	-155	24	N/A
12/31/2021	1,071	78	-126	22	N/A
9/30/2021	1,040	97	-65	59	N/A
6/30/2021	1,010	116	-4	97	N/A
3/31/2021	998	95	8	103	N/A
12/31/2020	987	73	20	109	N/A
9/30/2020	992	49	20	108	N/A
6/30/2020	997	24	19	107	N/A
3/31/2020	987	25	29	111	N/A
12/31/2019	976	26	38	114	N/A
9/30/2019	953	37	39	109	N/A
6/30/2019	930	48	40	105	N/A
3/31/2019	914	51	40	102	N/A
12/31/2018	897	54	39	100	N/A
9/30/2018	883	61	56	109	N/A
6/30/2018	869	69	74	119	N/A
3/31/2018	880	77	N/A	118	N/A
12/31/2017	892	85	N/A	118	N/A
9/30/2017	905	87	N/A	109	N/A
6/30/2017	918	89	N/A	101	N/A
3/31/2017	914	95	N/A	112	N/A
12/31/2016	911	102	N/A	123	N/A
9/30/2016	917	103	N/A	124	N/A
6/30/2016	922	104	N/A	126	N/A
3/31/2016	920	91	N/A	118	N/A
12/31/2015	918	78	N/A	110	N/A
9/30/2015	885	45	N/A	93	N/A
6/30/2015	851	13	N/A	75	N/A
3/31/2015	811	-4	N/A	71	N/A
12/31/2014	770	-21	N/A	67	N/A
9/30/2014	757	-15	N/A	51	N/A
6/30/2014	744	-9	N/A	34	N/A
3/31/2014	744	-3	N/A	22	N/A
12/31/2013	744	2	N/A	10	N/A

アナリストによる今後の成長予測

収入対貯蓄率: CRBNの予測収益成長率 (年間8.7% ) は貯蓄率 ( 1.2% ) を上回っています。

収益対市場: CRBNの収益 ( 8.7% ) Dutch市場 ( 16.2% ) よりも低い成長が予測されています。

高成長収益: CRBNの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: CRBNの収益は今後 3 年間で減少すると予想されています (年間-0.2% )。

高い収益成長: CRBNの収益は今後 3 年間で減少すると予測されています (年間-0.2% )。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: CRBNの自己資本利益率は、3年後には低くなると予測されています ( 11.3 %)。

Corbion 将来の成長

Future 基準チェック /16

主要情報

今後の成長に関する最新情報

Consensus EPS estimates increase by 18%

Price target decreased by 9.5% to €22.10

Price target decreased by 9.7% to €26.33

Consensus EPS estimates fall by 10%, revenue upgraded

Consensus EPS estimates fall by 26%, revenue upgraded

Price target decreased by 14% to €31.63

Recent updates

Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?

An Intrinsic Calculation For Corbion N.V. (AMS:CRBN) Suggests It's 26% Undervalued

Now 21% undervalued

New major risk - Revenue and earnings growth

Corbion N.V. to Report Q2, 2025 Results on Jul 31, 2025

Corbion (AMS:CRBN) Takes On Some Risk With Its Use Of Debt

First half 2024 earnings released: EPS: €0.39 (vs €0.26 in 1H 2023)

The Price Is Right For Corbion N.V. (AMS:CRBN)

Corbion N.V. (AMS:CRBN) Shares Could Be 25% Below Their Intrinsic Value Estimate

Now 20% undervalued

Here's Why Shareholders Should Examine Corbion N.V.'s (AMS:CRBN) CEO Compensation Package More Closely

Final dividend of €0.61 announced

Now 23% overvalued

Does Corbion (AMS:CRBN) Have A Healthy Balance Sheet?

Corbion Appoints Masha Vis-Mertens as Chief Human Resources Officer and Member of the Executive Committee as of 1 May 2024

Kingswood Capital Management, L.P. completed the acquisition of Emulsifiers business from Corbion N.V.

Corbion Announces Preliminary Results of New Study from Millennial Salmon Project

Dividend of €0.61 announced

Full year 2023 earnings: EPS exceeds analyst expectations

Consensus EPS estimates increase by 18%

Price target decreased by 9.5% to €22.10

Investor sentiment improves as stock rises 22%

Kingswood Capital Management, L.P. singed a binding agreement to acquire Emulsifiers business from Corbion N.V for $362 million.

Investor Optimism Abounds Corbion N.V. (AMS:CRBN) But Growth Is Lacking

Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?

Corbion N.V. to Report Fiscal Year 2023 Results on Mar 01, 2024

Estimating The Fair Value Of Corbion N.V. (AMS:CRBN)

Price target decreased by 9.7% to €26.33

Consensus EPS estimates fall by 10%, revenue upgraded

Corbion (AMS:CRBN) Has A Somewhat Strained Balance Sheet

First half 2023 earnings released: EPS: €0.48 (vs €0.88 in 1H 2022)

Returns On Capital Signal Tricky Times Ahead For Corbion (AMS:CRBN)

When Should You Buy Corbion N.V. (AMS:CRBN)?

Consensus EPS estimates fall by 26%, revenue upgraded

Price target decreased by 14% to €31.63

New minor risk - Dividend sustainability

Corbion N.V. (AMS:CRBN) Shares Could Be 22% Above Their Intrinsic Value Estimate

Corbion N.V. Approves Dividend for the Year 2022, Payable on 30 May 2023

Upcoming dividend of €0.56 per share at 1.9% yield

Insider recently bought €142k worth of stock

Here's Why Corbion (AMS:CRBN) Has A Meaningful Debt Burden

Consensus EPS estimates fall by 16%, revenue upgraded

Corbion (AMS:CRBN) Is Paying Out A Dividend Of €0.56

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Is Now An Opportune Moment To Examine Corbion N.V. (AMS:CRBN)?

Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business

Price target increased to €36.28

Is Corbion (AMS:CRBN) Using Too Much Debt?

Corbion N.V. Appoints Jennifer Lindsey as Chief Marketing and Digital Officer

Calculating The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

Price target decreased to €33.03

Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?

Corbion (AMS:CRBN) Might Be Having Difficulty Using Its Capital Effectively

Here's Why Corbion (AMS:CRBN) Has A Meaningful Debt Burden

Now 20% undervalued after recent price drop

A Look At The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

First half 2022 earnings released

Investor sentiment improved over the past week

Is It Time To Consider Buying Corbion N.V. (AMS:CRBN)?

Investors Could Be Concerned With Corbion's (AMS:CRBN) Returns On Capital

Corbion (AMS:CRBN) Is Due To Pay A Dividend Of €0.56

Corbion N.V. Announces Executive Changes

Calculating The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

Upcoming dividend of €0.56 per share

Consensus forecasts updated

Corbion (AMS:CRBN) Is Due To Pay A Dividend Of €0.56

Price target decreased to €40.82

Corbion (AMS:CRBN) Has Announced A Dividend Of €0.56

Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business